The Value Signal — April 28, 2026

247 articles scanned · 17 high-signal

Signal Map

Executive Summary

CMS is accelerating the next phase of value-based care, crystallizing its "Make America Healthy Again" vision through ambitious models like ACCESS and recalibrated quality frameworks, while bundled payment and specialty pharmacy pilots drive measurable cost and outcome gains.

The ACCESS Model marks a strategic inflection point for CMMI, combining evidence-based prevention, patient empowerment, and fiscal stewardship, according to Healthcare Economist. MedCity News underscores how ACCESS validates long-standing safety-net innovations and signals CMS's intent to scale proven solutions as part of its broader transformation agenda.

Bundled Payment models are delivering tangible results: AJMC reports that the Oncology Care Model has reduced chemotherapy utilization and Medicare spending for poor-prognosis cancers, while Becker's ASC highlights new opportunities in CMS's proposed total joint replacement model, which could further align provider incentives with patient outcomes.

A new wave of Value-Based Care integration is taking shape, with Harvard Medical School detailing lessons from the Oncology Care Model's impact on cost and quality, and Managed Healthcare Executive pointing to specialty pharmacy coaching as a lever for improved diabetes outcomes and lower costs. Digital enablement is accelerating, as Healthcare IT Today notes Aledade's integration of VBC data into EHR workflows, while news.google.com coverage tracks market optimism driven by DaVita's profitable kidney care platform and broader VBC service advancements.

The Quality Measures landscape is being reengineered: NCQA's freeze of HEDIS 2026 technical specifications brings stability to reporting, while McKnight's Senior Living and Home Health Care News describe CMS's proposed 2028 Medicaid HCBS quality measures, which are broadly supported by provider groups but not without reservations regarding implementation.

Medicare payment and performance frameworks are concurrently in flux, with HFMA summarizing the FY 2027 IPPS/LTCH PPS proposed rule's implications, Hooper Lundy noting cuts to the Excellent Health Outcomes for All Reward Program, and Wakely analyzing the impact of Star Rating changes finalized in the 2027 Medicare Advantage and Part D Final Rule.